HAPTOGLOBIN AS A BIOMARKER FOR CEREBRAL PALSY IN NEWBORNS

摘要

A method of diagnosing a newborn as having an increased risk of developing cerebral palsy is described. The method includes obtaining a biological sample from the newborn; determining the level of Hp and/or HpRP in the biological sample and comparing it to a control value; determining the level of IL-6 in the biological sample and comparing it to a control value; and diagnosing the newborn as having an increased risk of developing cerebral palsy if the level of Hp and/or HpRP is lower than the control value, and the level of IL-6 is greater than the control value. Also described is a method of diagnosing a newborn as having an increased risk of developing retinopathy of prematurity.